Ind-Swift Laboratories (NSE:INDSWFTLAB) Construction In Progress: ₹102 Mil (As of Mar. 2026)


NSE:INDSWFTLAB Ind-Swift Laboratories Ltd NSE:INDSWFTLAB
55 GF Score
Price ₹221.74
GF Value ₹36.93
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Ind-Swift Laboratories Construction In Progress?

Ind-Swift Laboratories NSE:INDSWFTLAB +3.54% 55 Construction In Progress is ₹102 Mil as of Mar. 2026. GuruFocus rates NSE:INDSWFTLAB with a GF Score™ of 55/100 and a GF Value™ of ₹36.93 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Ind-Swift Laboratories's quarterly construction in progress stayed the same from Sep. 2025 (₹0 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹102 Mil).

Ind-Swift Laboratories's annual construction in progress declined from Mar. 2024 (₹665 Mil) to Mar. 2025 (₹201 Mil) and declined from Mar. 2025 (₹201 Mil) to Mar. 2026 (₹102 Mil).

Ind-Swift Laboratories Construction In Progress Historical Data

* Premium members only.

The historical data trend for Ind-Swift Laboratories's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ind-Swift Laboratories Construction In Progress Chart

Ind-Swift Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 103.58 86.64 664.65 201.48 102.02

Ind-Swift Laboratories Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 201.48 0.00 0.00 102.02
NSE:INDSWFTLAB
55GF Score
Ind-Swift Laboratories Ltd NSE:INDSWFTLAB
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ind-Swift Laboratories Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹102 Mil mean?
Ind-Swift Laboratories (NSE:INDSWFTLAB) has a Construction In Progress of ₹102 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Ind-Swift Laboratories and its competitors.
Is Ind-Swift Laboratories' Construction In Progress too high?
Ind-Swift Laboratories' current Construction In Progress is ₹102 Mil. Overall, Ind-Swift Laboratories has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ind-Swift Laboratories' Construction In Progress compare to ZTS and UTHR?
Ind-Swift Laboratories' Construction In Progress of ₹102 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Ind-Swift Laboratories and its competitors. Ind-Swift Laboratories's current Construction In Progress is ₹102 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ind-Swift Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Ind-Swift Laboratories (NSE:INDSWFTLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹36.93, compared to a current price of ₹221.74 — trading 500.4% above its estimated fair value. The current Construction In Progress is ₹102 Mil. Ind-Swift Laboratories' overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Ind-Swift Laboratories (NSE:INDSWFTLAB), the current Construction In Progress is ₹102 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ind-Swift Laboratories (NSE:INDSWFTLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Ind-Swift Laboratories stock appears to be overvalued. The current stock price of ₹221.74 is trading 500.4% above its estimated GF Value™ of ₹36.93. GuruFocus considers Ind-Swift Laboratories to be Significantly Overvalued.

Key valuation signals for NSE:INDSWFTLAB:

  • Construction In Progress: ₹102 Mil
  • GF Value™: ₹36.93 vs. price of ₹221.74 (500.4% above fair value)
  • GF Score™: 55/100 with 4 warning signs

No single metric tells the full story. See the NSE:INDSWFTLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ind-Swift Laboratories Business Description

Other Exchanges 532305:India
Address SCO 850, NAC, Shivalik Enclave, Manimajra, Chandigarh, PB, IND, 160101
Ind-Swift Laboratories Ltd is involved in manufacturing Active Pharmaceutical Ingredients (API), Intermediates, and formulations. The company serves various therapeutic segments, including Cardiovascular health, Antihistamines, Antidiabetics, Antipsychotics, Parkinson's disease, Antineoplastics, ADHD Symptoms, Analgesics, Alcohol Abstinence, and Bone Resorption Inhibitors. It operates solely in the pharmaceutical products sector. Geographically, the company supplies both domestic and international markets, with the majority of its revenue coming from outside India.
55GF Score

Get the complete analysis for NSE:INDSWFTLAB

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹221.74
Price
₹36.93
GF Value